WeVote
Log In

Bill

Bill

HR 9117

To promote the availability of ceratin health care information, and for other purposes.

119th Congress Introduced by Nick Langworthy

The bill aims to enhance public access to health care information by standardizing and expanding how data such as prices and quality metrics are disseminated to patients and provid

Introduced in House
0
WeVote Research Nonpartisan
Bill Summary · HR 9117

Summary of HR 9117 (Session 119)

Purpose and intent

  • HR 9117 is a House bill titled: “To promote the availability of certain health care information, and for other purposes.”
  • The central aim, as suggested by the title, is to enhance access to health care information. The legislative text would detail the exact information targeted (for example, health care quality data, cost information, provider directories, patient resources, or transparency-related disclosures) and the mechanisms by which it should be made more available.
  • The bill was introduced in the House and includes bipartisan sponsorship (Co-sponsor: Nick Langworthy). It has been referred to multiple committees for consideration.

Key provisions and changes (high-level overview)

Note: The exact statutory text is not provided here, but the bill’s title indicates the following typical elements to expect in similar legislation:
- Establishment or expansion of requirements to disseminate health care information to the public, patients, providers, or payers.
- Provisions to standardize the format, accessibility, and timeliness of information (e.g., making data more user-friendly, searchable, or interoperable with existing health IT systems).
- Possible requirements for federal agencies or departments to collect, compile, and publish specific health care data (e.g., prices, quality metrics, availability of services, or network adequacy).
- Potential coordination with existing programs (e.g., within the Department of Health and Human Services, Agency for Healthcare Research and Quality, Centers for Medicare & Medicaid Services, or the Federal Trade Commission) to ensure dissemination and accessibility.
- Provisions to protect patient privacy and security while increasing transparency.
- Possible penalties, enforcement mechanisms, or timelines for implementing the information-sharing requirements.
- Public-facing resources or portals, consumer education initiatives, and support for health literacy.

Who would be affected

  • Federal agencies and departments responsible for health care information (likely including HHS agencies and possibly the FTC or other agencies depending on the exact provisions).
  • Health care providers, payers, and health plans may be subject to new reporting requirements or methods to present information.
  • Patients and consumers would gain greater access to health care information, potentially affecting choices about providers, plans, and treatments.
  • Researchers and health IT/information technology vendors could see new data standards or accessibility requirements.

Procedural and timeline aspects

  • The bill was introduced in the House and subsequently referred to multiple committees: Energy and Commerce, Education and Workforce, and Ways and Means. The referral “for consideration of such provisions as fall within the jurisdiction of the committee concerned” indicates that different portions of the bill may be handled by different committees.
  • Tracking history shows a standard early-stage committee referral process, with possible further hearings, markup, or amendments in the respective committees.
  • Specific implementation timelines (e.g., effective dates, phased-in requirements) would be defined in the text of the bill or accompanying statements; such details are not provided here.

Context and considerations

  • The bill aligns with ongoing policy interests in health care transparency and consumer access to information.
  • As with any information-sharing or data-standardization effort, key considerations include privacy protections, data accuracy, user accessibility, cost of compliance for providers and payers, and potential effects on market competition and consumer decision-making.

If you’d like, I can pull in the exact text or any committee reports to provide precise provisions, dates, and dollar figures once they’re available.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.